InvestSMART

Neurotech International Limited (ASX: NTI) - Announcements

- Current share price for NTI : $0.015

ASX company news and announcements for Neurotech International Limited (NTI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurotech International Limited (NTI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurotech International Limited (NTI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurotech International Limited (NTI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Neurotech Completes $9.0M Placement 28 Oct 2022 9:45AM $0.130 $0.015 fallen by 88.85%
$23 Suspension From Official Quotation 27 Oct 2022 9:38AM $0.130 $0.015 fallen by 88.85%
$23 20 Week Data Shows Significant Improvement For ASD Children 26 Oct 2022 9:43AM $0.130 $0.015 fallen by 88.85%
$23 Application for quotation of securities - NTI 25 Oct 2022 6:57PM $0.130 $0.015 fallen by 88.85%
$23 Trading Halt 25 Oct 2022 9:44AM $0.130 $0.015 fallen by 88.85%
$23 Upcoming Presentation at South-West Connect ASX Showcase 19 Oct 2022 8:16AM $0.105 $0.015 fallen by 86.19%
$23 New Phase I/II Clinical Trial in Children with PANDAS/PANS 17 Oct 2022 8:12AM $0.100 $0.015 fallen by 85.50%
$23 Application for quotation of securities - NTI 12 Oct 2022 7:48PM $0.105 $0.015 fallen by 86.19%
$23 Proposed issue of securities - NTI 11 Oct 2022 5:45PM $0.105 $0.015 fallen by 86.19%
$23 Autism Spectrum Disorder Phase I/II Clinical Trial Update 15 Sep 2022 9:48AM $0.094 $0.015 fallen by 84.57%
$23 NTI to Present at ASX Small to Mid-Cap Investor Conference 9 Sep 2022 12:55PM $0.100 $0.015 fallen by 85.50%
$23 Initial Director's Interest Notice 8 Sep 2022 1:51PM $0.099 $0.015 fallen by 85.35%
$23 Application for quotation of securities - NTI 6 Sep 2022 5:00PM $0.094 $0.015 fallen by 84.57%
$23 Neurotech to present at E&P Small Cap Healthcare Conference 6 Sep 2022 4:00PM $0.094 $0.015 fallen by 84.57%
$23 Executive Change 1 Sep 2022 4:23PM $0.105 $0.015 fallen by 86.19%
$23 Appendix 4G and Corporate Governance Statement 31 Aug 2022 6:32PM $0.100 $0.015 fallen by 85.50%
$23 Appendix 4E & Annual Report 31 Aug 2022 6:30PM $0.100 $0.015 fallen by 85.50%
$23 Final Director's Interest Notice x2 16 Aug 2022 6:33PM $0.110 $0.015 fallen by 86.82%
$23 Proposed issue of securities - NTI 16 Aug 2022 9:08AM $0.110 $0.015 fallen by 86.82%
$23 Proposed issue of securities - NTI 16 Aug 2022 9:05AM $0.110 $0.015 fallen by 86.82%
$23 Consultant Appointment and Board Changes 16 Aug 2022 9:02AM $0.110 $0.015 fallen by 86.82%
$23 Change of Director's Interest Notice 3 Aug 2022 8:23AM $0.090 $0.015 fallen by 83.89%
$23 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2022 10:26AM $0.088 $0.015 fallen by 83.52%
$23 Q&A on NTI164 Breakthrough Clinical Trial Results in ASD 22 Jul 2022 8:40AM $0.072 $0.015 fallen by 79.86%
$23 Initial Director's Interest Notice 13 Jul 2022 6:34PM $0.070 $0.015 fallen by 79.29%

301 - 325 of 694 results

Page 13 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.